Acral Lentiginous Malignant Melanoma

Also known as: Acral Melanoma / Acral lentiginous melanoma / Acral lentiginous melanoma, malignant (morphologic abnormality) / Malignant acral lentiginous melanoma / Acral lentiginous malignant melanoma of skin (disorder)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00531Cyclophosphamide1Recruiting1
DB00997Doxorubicin1Terminated1
DB01073Fludarabine1Recruiting1
DB14865Human interleukin-21Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB09037Pembrolizumab1Terminated1
DB00062Albumin human1 / 2Recruiting1
DB14865Human interleukin-21 / 2Recruiting1
DB09037Pembrolizumab1 / 2Recruiting1
DB11967Binimetinib2Recruiting1
DB14776Camrelizumab2Recruiting2
DB04849Cediranib2Completed1
DB12021Dinaciclib2Active Not Recruiting1
DB11718Encorafenib2Recruiting1
DB00619Imatinib2Completed1
DB06186Ipilimumab2Recruiting1
DB06186Ipilimumab2Unknown Status1
DB04868Nilotinib2Completed2
DB09035Nivolumab2Recruiting1
DB09035Nivolumab2Unknown Status1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Completed1
DB09037Pembrolizumab2Not Yet Recruiting1
DB11870RG-47332Terminated1
DB14765Rivoceranib2Recruiting2
DB01268Sunitinib2Completed1
DB00853Temozolomide2Recruiting1
DB15310Vactosertib2Not Yet Recruiting1
DB14776Camrelizumab3Recruiting1
DB14765Rivoceranib3Recruiting1
DB00853Temozolomide3Recruiting1